The Egyptian Orthopaedic Journal,
Год журнала:
2023,
Номер
58(2), С. 67 - 82
Опубликована: Апрель 1, 2023
Abstract
Background
The
pandemic
of
COVID-19
virus
had
led
to
another
avascular
necrosis.
Aim
To
evaluate
the
altered
clinical
and
radiological
presentation
COVID-19-related
AVN
hip.
Methods
This
study
included
42
patients
with
head
femur
who
were
presented
outpatient
clinic
Kafr
El
Sheikh
University
Hospital.
Patients
classified
into
three
main
groups.
first
group
COVID
infection
received
steroid
therapy
for
their
pulmonary
manifestations.
second
without
receiving
therapy.
final
hip
after
vaccination
taking
any
Results
related
infection.
more
susceptible
development
at
(a)
lower
threshold
dose
(900
g)
(b)
earlier
onset
(less
than
a
month).
Conclusions
conclude,
there
is
silent
epidemic
cases
presenting
daily
in
our
clinics
AVN.
International Journal of Infectious Diseases,
Год журнала:
2022,
Номер
121, С. 11 - 13
Опубликована: Апрель 21, 2022
Recovery
from
COVID-19
is
not
always
uneventful,
especially
in
critically
ill
hospitalized
patients.
Persistent
symptoms
including
fatigue/
weakness,
shortness
of
breath,
anxiety,
and
depression
have
been
described
at
one-year
follow-up.
Furthermore,
the
musculoskeletal
system
like
joint
pain
or
stiffness
are
underreported
studies
with
long-term
follow-up
up
to
one
year.
Infection
SARS-CoV-2
itself
has
associated
endothelial
damage,
together
high-dose
corticosteroid
treatment,
it
predisposed
dissemination
microthrombi
development
femoral
head
osteonecrosis
(FHOn),
as
shown
during
previous
(2003–2004)
coronavirus
outbreaks.
A
resurgence
FHOn
cases
anticipated
but
this
reflected
existing
Prompt
diagnosis
critical
for
early
treatment
possibly
hip
preservation.
Patients
treated
corticosteroids
should
be
screened
avascular
necrosis
after
discharge
hospital.
Every
healthcare
worker
involved
management
these
patients
maintain
a
high
level
suspicion
alert
when
report
such
vague
aches
buttocks,
area,
adductors,
and/or
above
knee.
Studies
needed
identify
risk
factors
disease
severity,
type
steroid,
cumulative
dose,
duration
treatment.
Life,
Год журнала:
2023,
Номер
13(4), С. 907 - 907
Опубликована: Март 29, 2023
Corticosteroids
(CS)
have
been
used
in
the
management
regimens
for
COVID-19
disease
to
mitigate
cytokine
storm
and
ill
effects
of
pulmonary
inflammatory
cascade.
With
rampant
use
CS,
clinicians
started
reporting
occurrence
osteonecrosis
femoral
head
(OFH).
In
this
systematic
review,
we
aim
analyze
literature
identify
definitive
cumulative
dose
duration
CS
needed
development
OFH
based
on
SARS
model
generate
a
risk-based
screening
recommendation
convalescent
patients
facilitate
early
identification
management.
An
electronic
database
search
was
conducted
until
December
2022
PubMed,
Web
Science,
Embase,
CNKI
(China
Knowledge
Resource
Integrated
Database).
Studies
involving
therapy
data
were
included.
Three
authors
independently
extracted
from
included
studies
dose–response
meta-analysis
performed
various
doses
utilized
studies.
We
selected
12
articles
with
1728
analysis.
The
mean
age
33.41
(±4.93)
years.
dosage
administered
4.64
(±4.7)
g
which
29.91
(±12.3)
days.
risk
increases
at
pooled
OR
1.16
(95%
CI
1.09–1.23,
p
<
0.001)
per
2.0
increase
usage.
Similarly,
1.02
1.01–1.03,
5
days
A
4
15
determined
as
critical
cut-off
non-linear
relationship
observed.
Appropriate
frequent
these
individuals
regular
intervals
would
help
an
stage
order
treat
them
appropriately.
International Journal of Rheumatic Diseases,
Год журнала:
2023,
Номер
27(1)
Опубликована: Дек. 22, 2023
The
consequences
of
the
Coronavirus
Disease
2019
(COVID-19)
pandemic,
caused
by
Severe
Acute
Respiratory
Syndrome
2
(SARS-CoV-2),
will
have
a
lasting
effect
on
health
global
population.
This
disease
most
likely
be
viewed
as
plague
21st
century.
true
toll
COVID-19
pandemic
is
difficult
to
estimate
due
its
immediate
and
delayed
consequences.
Reportedly,
about
700
mLn
people
worldwide
been
infected
with
SARS-CoV-2
7
them
died
(https://www.worldometers.info/coronavirus/).
In
post-pandemic
period,
upsurge
autoimmune
rheumatic
diseases
(ARDs)
has
observed
among
survivors
those
exposed
vaccinations.
mainstream
rheumatology
sources
including
International
Journal
Rheumatic
Diseases
(IJRD)
taken
lead
in
discussing
clarifying
plausible
associations
between
autoimmunity.1,
Importantly,
this
year's
Annual
European
Congress
Rheumatology
arranged
special
session
titled
"Can
induce
autoimmunity
musculoskeletal
diseases?"
(EULAR
2023
Debate,
June
2023).
latest
editorial
IJRD
uncovered
association
Rheumatoid
Arthritis
(RA)1
referred
our
study
definite
RA
after
exposure
SARS-CoV-2.3
commonest
prototype
ARD.
spreading
may
reflect
trends.
As
such,
we
aimed
analyze
official
morbidity
records
Kazakhstan,
Kyrgyzstan,
Uzbekistan,
Tajikistan
peri-pandemic
period
(2019–2022),
year
took
last
before
pandemic.
We
formulated
research
question
reveal
any
trend
numbers
3
years.
retrieved
from
statistical
yearbooks
four
Central
Asian
countries.
analysis
data
revealed
substantial
increase
absolute
relative
number
patients
was
registered
dispensary
follow-up
subjects
newly
diagnosed
diseases.
Kazakhstan
elevated
41
044
2020
66
018
2022,
accounting
for
61%
increase.
Such
an
accompanied
disproportionately
slow
general
Kazakhstani
population
(10.4%
past
years).
Uzbekistan
Kyrgyzstan
accounted
29%
31%,
respectively,
during
same
period.
Tajikistan,
increased
24.4%
(from
10
541
13
112
2022)
while
5.8%.
Back
2020,
presented
hypothesis
potential
trigger
at
APLAR
congress
published
related
abstract
October
2020.
hypothesis,
enriched
growing
evidence,
discussed
publication
2022.4
With
time
passing
accumulating
similar
hypotheses
COVID-19-induced
were
tested
large
studies
crystallizing
scientific
fact
association.
Indeed,
cohort
Taiwan,
Germany,
UK,
South
Korea,
2023,
confirmed
that
infection
associated
ARD
morbidity.5-8
Notably,
German
641
704
COVID-19,
matched
controls,
there
43%
higher
likelihood
acquiring
new
within
3–15
months
infection.6
vaccination
campaign
raised
concerns
over
scale
adverse
outcomes
autoimmunity.
numerous
cases
vaccination-associated
described,
generating
hypotheses.9
vaccinations
saved
millions
lives
changed
course
Nonetheless,
coupled
infections
could
triggering
predisposed
established
ARDs.10
Osteonecrosis
yet
another
big
issue
amid
pandemic.11,
12
Several
factors
implicated
pathophysiology
debilitating
complication
which
irrational
corticosteroid
therapy.
It
seems
developing
world,
central
countries,
encounter
osteonecrosis
unjustified
widespread
use
corticosteroids
outpatient
inpatient
settings.
Rheumatologists
like
no
other
specialists
are
familiar
severe
complications
therapies
take
timely
diagnosing
managing
aftermath
Admittedly,
ARDs
not
entirely
A
recent
article
series
Lancet
disorders
30
years,
unrelated
pandemic.13-15
Moreover,
shown
natural
selection
mutations
genes
responsible
innate
immunity
led
resistance
infections,
coming
cost
inflammatory
human
populations.16
An
increasing
interest
these
continuously
advancing
diagnostics
also
contribute
impressive
ARDs.
For
instance,
qualified
rheumatologists
doubled
partly
contributing
statistics
field.
To
sum
up,
had
profound
landscape
necessitates
more
concerted
actions
national
regional
levels.
expected
stretching
resources.
action
rheumatologists,
who
member
APLAR,
increasingly
important
face
need
training
specialists,
expanding
units,
supplying
drugs.
come
reach
consensual
statement
rheumatologists.17
serve
platform
initiating
discussion
whereas
help
launch
working
group
recommendations.
Chokan
Baimukhamedov
wrote
manuscript
input
all
authors.
All
authors
reviewed
results
approved
final
version
manuscript.
None.
None
declared.
Data
sharing
applicable
created
or
analyzed
study.
PubMed,
Год журнала:
2023,
Номер
11(12), С. 731 - 737
Опубликована: Янв. 1, 2023
Based
on
WHO
data,
as
of
June
2022,
there
were
532.2
million
confirmed
COVID-19
cases
globally.
In
the
initial
phase
COVID
-19
pandemic,
patients
experiencing
critical
illness
marked
by
severe
respiratory
distress
commonly
subjected
to
corticosteroid
treatment.
Regrettably,
administration
exogenous
corticosteroids
stands
prevailing
cause
ONFH.
current
narrative
review,
we
aim
evaluate
if
active
screening
should
be
utilized
diagnose
post-COVID-19
ONFH
in
its
early
stages.The
databases
for
PubMed,
CINAHL,
and
Science
Direct
systematically
queried
March
2022.
The
search
terms
follows:
"COVID-19",
"severe
acute
syndrome",
"coronavirus",
"systemic
steroid",
"corticosteroid",
"femoral
head
osteonecrosis",
"avascular
necrosis",
or
"steroid
therapy."
included
studies
review
all
required
peer-reviewed
English
language
with
Reported
complications
linked
steroid
therapy
potential
connections
development
individuals
recovering
from
novel
coronavirus
have
been
documented.Systemic
frequently
employed
managing
critically
ill
patients.
CDC
reports
up
2022
showed
more
than
4.8
hospitalizations
US,
approximately
over
one
receiving
steroids.
a
study
after
infection
COVID-19,
had
bilateral
involvement.
average
duration
initiation
treatment
onset
symptoms
was
132.8
days.In
summary,
distinct
correlation
exists
between
steroids
subsequent
risk
Moreover,
an
elevated
dosage
prolonged
are
associated
increased
likelihood
developing
Therefore,
high-risk
patients,
that
may
received
systemic
during
illness,
reasonable.
Open Access Macedonian Journal of Medical Sciences,
Год журнала:
2024,
Номер
12, С. 1 - 7
Опубликована: Фев. 25, 2024
BACKGROUND:
Post-COVID
conditions
can
include
a
wide
range
of
ongoing
health
problems.
As
consequence
long
COVID-19
or
post-COVID-19
an
increase
in
osteonecrosis
has
been
detected
different
series
patients.
CASE
PRESENTATION:
We
present
two
patients
diagnosed
with
and
pneumonia,
one
moderate
the
other
severe
clinical
picture.
They
were
treated
corticosteroid
equivalent
to
prednisolone
993.5
mg
(400–1587
mg)
which
correlates
steroid
dose
documented
literature
as
causative
for
avascular
necrosis
(ANV)
COVID-19.
After
mean
time
65
days,
due
pain
groin
difficulty
movement,
magnetic
resonance
imaging
(MRI)
was
performed
both
AVN
diagnosed.
Compared
our
results,
records
longer
required
development
without
COVID-19,
is
6–36
months.
This
indicates
potency
virus
itself
cause
disturbances
microcirculation,
thus
AVN.
The
bone
damage
degree
inflammation
severity
CONCLUSION:
course
part
ANV
should
be
considered
possible
complication,
especially
who
have
manifestations.
Early
detection
diagnosis
using
MRI
on
suspicion
would
help
early
intervention
bisphosphonate
therapy
hip.
If
disease
more
advanced
stage,
it
necessary
perform
surgical
even
hip
replacement.
WORLD JOURNAL OF PLASTIC SURGERY,
Год журнала:
2024,
Номер
13(1), С. 96 - 102
Опубликована: Янв. 1, 2024
Many
people
were
affected
by
COVID-19
in
its
severe
form.
Some
intercurrences
are
still
emerging.
We
here
report
two
cases
of
COVID-related
osteonecrosis
the
jaws
(CRONJ).
Two
retrospective
admitted
into
Imam
Reza
Hospital,
Mashhad,
Iran
with
suspected
CRONJ.
One
patient
escaped
from
hospital
while
other
showed
a
positive
result
after
our
proposed
treatment.
A
new
aftermath
to
infections
is
Maxillofacial
and
orthopedic
surgeons
should
be
aware
this
situation.
CRONJ
on
suspect
list
patients
COVID-19.
Measures
that
useful
treatment
carried
out,
as
well
some
measures
recommended
literature,
discussed.
Surgical
appears
an
effective
alternative,
especially
more
aggressive
cases.
Rheumatology Science and Practice,
Год журнала:
2023,
Номер
61(2), С. 220 - 235
Опубликована: Апрель 28, 2023
Avascular
necrosis
(AN)
of
bone
tissue
is
a
common
pathology
that
affects
people
any
age,
more
often
young
and
able-bodied.
The
disease
leads
to
rapid
destruction
the
subchondral
collapse,
followed
by
development
secondary
osteoarthritis
(OA)
affected
joint.
purpose
this
review
article
present
accumulated
knowledge
about
prevalence
AN,
most
commonly
joints,
risk
factors
pathogenesis
disease.
Since
world’s
literature
sources
individual
parts
facts
make
up
analyzes
all
known
paths
from
onset
ischemia
collapse
OA
presented
in
chronological
order.
Based
on
results
article,
definition
term
AN
was
proposed,
stages
within
pathogenesis,
promising
for
conservative
methods
treatment,
were
identified.
Rheumatology Science and Practice,
Год журнала:
2023,
Номер
61(1), С. 34 - 41
Опубликована: Март 2, 2023
The
impact
of
the
transferred
coronavirus
infection
on
musculoskeletal
system
still
remains
an
urgent
problem.
Аrthralgia,
myalgia,
arthritis,
autoimmune
disorders
and
also
osteonecrosis
are
may
be
development
postCOVID
period.
This
article
discusses
case
debut
multifocal
after
a
infection.
Kazan medical journal,
Год журнала:
2023,
Номер
104(4), С. 552 - 563
Опубликована: Июнь 28, 2023
The
review
article
is
devoted
to
one
of
the
new
topical
problems
in
medicine
necrosis
organs
cranio-maxillofacial
region
patients
with
coronavirus
infection,
which
was
first
discussed
at
end
2020.
Later,
doctors
various
specialties
(otolaryngologists,
ophthalmologists,
maxillofacial
surgeons,
neurosurgeons,
dentists)
from
many
countries
world
met
their
practice
inflammatory-necrotic
lesions
mucous
membrane
nasal
cavity
and
paranasal
sinuses,
facial
skeleton
skull,
eyeball,
brain.
highlights
main
points
view
scientists
about
etiology
pathogenesis
studied
pathology.
Summarized
data
largest
studies
on
epidemiology,
risk
factors,
symptoms
post-covid
are
presented.
results
methods
for
diagnosing
this
complication
multislice
computed
tomography,
magnetic
resonance
imaging,
angiography,
described
detail.
Due
fact
that
today
role
fungal
flora
recognized
as
leading
region,
much
attention
paid
cytological,
microbiological
pathohistological
research
methods,
should
be
aimed
search
mycelium.
approaches
treatment
pathology
formulated.
issues
important
practical
healthcare:
interpretation
national
clinical
guidelines
infection
terms
classification
options
according
International
Classification
Diseases
10th
revision,
procedure
providing
medical
care
category
patients,
economic
consequences
lack
active
prevention
presented
COVID-19.